Spontaneous regression of cancer: Possible mechanisms

In Vivo

Volumn 12, Issue 6, 1998, Pages 571-578

  Papac, Rose J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Human cancer; Mechanisms; Spontaneous regression

Indexed keywords

CARCINOGEN; CYTOKINE; GROWTH FACTOR; HORMONE; METHOTREXATE;

ANGIOGENESIS; APOPTOSIS; CANCER; CANCER REGRESSION; HUMAN; KIDNEY CARCINOMA; LEUKEMIA; LYMPHOMA; MELANOMA; NEUROBLASTOMA; PSYCHOLOGICAL ASPECT; REVIEW; TUMOR DIFFERENTIATION; TUMOR IMMUNITY; TUMOR NECROSIS;

EID: 0032422764     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Rohdenburg GL: Fluctuations in the growth of malignant tumors / in man, with especial reference to spontaneous regression. J Cancer Res 3:192-221, 1918.
2. Everson TC and Cole WH: Spontaneous Regression of Cancer. Philadelphia, PA: W.B. Saunders, 1966.
3. Natl Cancer Inst. Monogr. Spontaneous Regression of Cancer. 1976.
4. Boyd W: .The Spontaneous Regression of Cancer. Springfield, IL: Charles C. Thomas, 1966.
5. Challis GB and Stam HJ: The spontaneous regression of cancer. A review of cases from 1900 to 1987. Acta Oncol 29:545-549, 1990.
6. O'Regan B and Hirschberg C: Spontaneous Remission. An Annotated Bibiography. Sausalito, CA: Institute of Noetic Sciences, 1993.
7. Stoll BA: Spontaneous regression of cancer: new insights. Biotherapy 4: 23-30, 1992.
8. Papac RJ: Spontaneous regression of cancer. Cancer Treat Rev 395-423, 1996.
9. Baker HW: Biologic control of cancer. Arch Surg 121: 1237-1241, 1986.
10. Salloum E, Cooper DL, Howe G et al: Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid disorders and other rheumatic diseases. J Clin Oncol 14:1943-1949, 1996.
11. Rabkin CS, Hilgartner MW, Hedberg KW et al: Incidence of lymphomas and other cancers in HIV-infected and HIV- uninfected patients with hemophilia. JAMA 267:1090-1094, 1992.
12. Penn I: Cancers complicating organ transplantation. N Eng J Med 323: 1767-1769, 1990.
13. Tebbe B, Mayer da Silva A, Garbe C et al: Genetically determined coincidence of Kaposi's sarcoma and psoriasis in an HIV negative patient after prednisolone treatment. Spontaneous regression 8 months after discontinuing therapy. Int J Dermatol 30: 114-120, 1991.
14. Viraben R, Brousse P and Lamant L: Reversible cutaneous lymphoma occurring during methotrexate therapy. Br J Dermatol 130: 1-8, 1996.
15. Danatal J, Hourmant J, Cantarovich D et al: Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosponn regimens. Lancet 351: 623-628, 1998.
16. Bernier M, Bagot, M, Broyer M et al: Distinctive clinicopathologic features associated with regressive primary CD30 positive cutaneous lymphomas: analysis of 6 cases. J Cutan Pathol 24: 157-163, 1997.
17. Arai E and Katayama I: Role of apoptosis in spontaneous regression of peripheral T-cell lymphoma arising in the skin or subcutis. Hum Pathol 28: 472-477, 1997.
18. Holder JE, Colloby PS, Fletcher A and Hutchinson PE: Regressing cutaneous lymphomas of T-cell and B-cell lineage. Br J Dermatol 32: 815-820, 1995.
19. de Berker D, Windebank K, Sviland L et al: Spontaneous regression in angiocentric T-cell lymphoma. Br J Dermatol 134: 554-558, 1996.
20. Mayou SC, Anstey A, Norton AJ et al: Angiocentric T-cell lymphoma in skin. J R Soc Med 84: 683-684, 1991.
21. Hunt MJ, Halliday GM, Weedon D et al: Regression in basal cell carcinoma: an immunohistochemical analysis. Br J Dermatol 130: 1-8, 1994.
22. Hood DB, Bowker RJ and Cochran AJ: Supressor cell activity in melanoma-draining lymph nodes. Cancer Res 47: 1529-1533, 1987.
23. Mackensen A, Ferradini, L, Carcelain G et al: Evidence for in situ amplification of cytotoxic T-lymphocytes with antitumor activity in a human regressive melanoma. Cancer Res 53: 3569-3573, 1993.
24. Lowes MA, Bishop GA, Crotty K et al: T helper 1 cytokine mRNA is increased in spontaneously regressing primary melanoma. J Invest Dermatol 108: 914-919, 1997.
25. Carcelain G, Rouas-Freiss N, Zorn E et al: In situ T-cell responses in a primary regressive melanoma and subsequent metastases: A comparative analysis. Int J Cancer 72: 241-247, 1997.
26. Cole WH: Spontaneous regression of cancer. The metabolic triumph of the host? Ann NY Acad Sci 230: 111-141, 1974.
27. Connelly TJ and Kowalcyk AP: Another case of spontaneous regression of Merkel cell (neuroendocrine) carcinoma. Dermatol Surg 23: 588-590, 1997.
28. O'Rourke M GE and Bell JR: Merkel cell tumor with spontaneous regression. J Dermatol Surg 12: 994-997, 1986.
29. Takenaka H, Kishimoto S, Shibagaki R: Merkel cell carcinoma with partial spontaneous regression. Amer J Dermatopath 19: 614-618, 1997.
30. Yanguas T, Goday JJ, Gonzalez-Guemes M et al: Spontaneous regression of Merkel cell carcinoma of the skin. Br J Dermatol 137: 296-298, 1997.
31. Strickler JG, Copenhaaver CM, Rojas VA et al: Comparison of "host infiltrates" in patients with follicular lymphoma with and without spontaneous regression. Am J Clin Pathol 90: 257-261, 1988.
32. Ono K, Kikuchi M, Funai N et al: Natural killing activity in patients with spontaneous regression of malignant lymphoma. J Clin Tmmunol 16: 334-339, 1996.
33. Hussel TW, Isaacson PH, Crabtree JE et al: The response of cells from low-grade gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 342: 571-574, 1993.
34. Bolande RP: The spontaneous regression of neuroblastoma: Experimental evidence for a natural host immunity. Pathol Annu 26: 187-199, 1991.
35. Ollert MW, David K, Schmitt C et al: Normal human serum contains a natural IgM antibody cytotoxic for human neuroblastoma cells. Proc Natl Acad Sci 93: 4498-4503, 1996.
36. Valteau D, Scott V, Carcelain G et al: T-cell receptor repertoire in neuroblastoma patients. Cancer Res 56: 362-369, 1996.
37. Hertz R: Spontaneous regression in choriocarcinoma and related gestational trophoblastic neoplasms. Natl Cancer Inst Monogr 44: 59-66, 1976.
38. Darnell RB and De Angelis LM: Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies. Lancet 341: 21-22, 1993.
39. Zaheer W, Friedland ML, Cooper EB et al: Spontaneous regression of small cell carcinoma of lung associated with severe neuropathy. Cancer Invest 1: 306-309, 1993.
40. Horn L and Horn H: An immunologic approach to the treatment of cancer? Lancet 2: 466-469, 1971.
41. Abukar YA, Chou TH and Redman BG: Spontaneous remission of renal cell carcinoma: a case report and immunological correlates. J Urol 152: 156-157, 1994.
42. Dao TL: Regression of pulmonary metastases of a breast cancer. Arch Surg 84: 574-577, 1962.
43. Gohji, K, Kizaki T and Fujii A: Spontaneous regression of pulmonary metastasis from nonfunctioning adrenocortical carcinoma after removal of the primary lesion: A case report. J Urol 154: 1854-1855, 1995.
44. Comiter CV, Renshaw AS, Benson CB and Loughlin KR: Burnedout primary testicular cancer: Sonographic and pathological characteristics. J Urol 156: 85-88, 1996.
45. Wiernik PH: Spontaneous regression of hematologic cancers. Natl Cancer Inst Monogr i35-88, 1976.
46. Lefrere F, Hermine O, Radford-Weiss, I et al: A spontaneous remission of lymphoid blast crisis in chronic myelogenous leukaemia following blood transfusion and infection. Br J Haematol 88: 621-622, 1994.
47. Tucker J, Murphy MF, Gregory WM et al: Appparent removal of graft-versus-leukaemia effect by the use of leucocyte-poor blood components in a patient with acute myeloblastic leukaemia. Br J Haematol 73: 572-573, 1989.
48. Renneboog B, Hansen P, Heimann A et al: Spontaneous remission in a patient with therapy-related myelodysplastic syndrome (t-MDS) with monosomy 7. Br J Haematol 92: 696-698, 1996.
49. Benaim E, Hvizdala EV, Papaenhausen P, Moscinski LC: Spontaneous remission in monosomy 7 myelodysplastic syndrome. Br J Haematol 59: 947-948, 1995.
50. MacManus MP, Harte RJ and Stranex S: Spontaneous regression of metastatic renal cell carcinoma following palliative irradiation of the primary tumor. Irish J Med Sci 163: 461-463, 1994.
51. Ambros PF, Ambros S, Strehl et al: Regression and progression in neuroblastoma. Does genetics predict tumour behavior? Eur J Cancer 31A: 510-5, 1995.
52. Kushner BH, Cheung NKKV, LaQuaglia MP et al: Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy. J Clin Oncol 14: 373-381, 1996.
53. Nakagawara A, Nakamura Y, Ikeda H: High levels of expression and nuclear localization of interleukin-1β converting enzyme (ICE) and CPP32 in favorable human neuroblastomas. Cancer Res 57: 4578-4584, 1997.
54. Musashi M, Abe S, Yamada T et al: Spontaneous remission in a patient with chronic myelogenous leukemia. N Eng J Med 336: 337-339, 1997.
55. Jimemez C, Ribera JM, Abad E et al: Increased tumour necrosis factor during transient remission in acute leukaemia. Lancet 341: 1600, 1993.
56. Musto P, D'Arena G, Melillo L et al: Spontaneous remission in acute myeloid leukemia: A role for endogenous production of tumour necrosis factor and interleukin-2? Br J Haematol 87: 879-880, 1994.
57. Delmer A, Heron E, Marie JP and Zittoun R: Spontaneous remission in acute myeloid leukemia. Br J Haematol 87: 880-881, 1995.
58. Bassan R, Rambaldi A, Amaru R et al: Unexpected remission of acute myeloid leukaemia after GM-CSF. Br J Haematol 87: 835-838, 1994.
59. Markovic S, Ferlan-Marollt V and Hlebanja Z: Spontaneous regression of hepatocellular carcinoma. Am J Gastroenterol 91: 392-393, 1995.
60. Castaigne S, Chomienne C, Daniel MT et al: All transretinoic acid as differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 76: 1704-1709, 1990.
61. Cushing H and Wollbach SSB: The transformation of a malignant paravertebral sympaathicoblastoma into a benign ganglioneuroma. Am J Pathol 3: 203-216, 1927.
62. Hong WK, Wittes RE, Hajdu ST et at: The evolution of mature teratoma from malignant testicular tumors. Cancer 40: 2987-2992, 1977.
63. Friedman SF and Skehan P: Morphological differentiation of human choriocarcinoma cells induced by methotrexate. Cancer Res 39: 1960-1967, 1979.
64. Ogihara Y, Takeda K, Yanagawa T and Hirasawa Y: Spontaneous regression of lung metastases from osteosarcoma. Cancer 74: 2798-2803, 1994.
65. Kramer MHH, Kluin PM, Wijburg ER et al: Differentiation of follicular lymphoma cells after autologous bone marrow transplantation and haematopoietic growth factor treatment. Lancet 345: 488-490, 1995.
66. Lewison EF: Spontaneous regression of breast cancer. Natl Cancer Inst Monogr 44: 23-26, 1976.
67. Ross MB, Buzdar AU, Hortobagyi G et al: Spontaneous regression of breast carcinoma: Follow-up report and literature review. J Surg Oncol 19: 22-24, 1982.
68. Powles TJ and Hickish T: Breast cancer response to hormone replacement therapy withdrawal. Lancet 345: 1442, 1995.
69. Schurmans JR, Blijenberg BG, Mickisch GH and Schroder FH: Spontaneous remission of a bony metastasis in prostatic adenocarcinoma. J Urol 155: 653, 1996.
70. Bissada NK and Kaczmarek AT: Complete remission of hormone refractory adenocarcinoma of the prostate in response to withdrawal of diethylstilbesterol. J Urol 153: 1944-1945, 1995.
71. Nathanson L: Spontaneous regression of malignant melanoma: A review of the literature on incidence, clinical features, and possible mechanisms. Natl Cancer Inst Monogr 44: 67-76, 1976.
72. Birge RF, Jenks AL and Davis SK: Spontaneous remission in acute leukemia: Report of a case complicated by eclampsia. JAMA 140: 589-592, 1949.
73. Cantini E and James B: Acute myelogenous leukemia in pregnancy. South Med J 77: 1050-1052, 1984.
74. Taetle R and Guittarad JPJ: Modulation of leukemia blast colony growth by steroid hormones. Br J Haematol 50: 247-255, 1982.
75. Johnson FL, Feagler JR, Lerner KG et al: Association of androgenic anabolic steroid therapy with development of hepatocellular carcinoma. Lancet 2: 1273-1276, 1972.
76. Jones RW: The natural history of vulvar intraepithelial neoplasia. Br J Obstet Gynaecol 102: 764-766, 1995.
77. Bos AB, van Ballegooijen M, van Oortmarssen GJ et al: Nonprogression of cervical intraepithelial neoplasia estimated from population-screening data. Br J Cancer 75: 124-130, 1997.
78. Harford FJ, Fazio VW, Epstein LM and Hewitt CB: Rectosigmoid carcinoma occurring after ureterosigmoidostomy. Dis Colon Rectum 27: 321-324, 1984.
79. Imaoka S, Sasaki Y, Masutani S et al: Necrosis of hepatocellular carcinoma caused by spontaneously arising arterial thrombus. Hepato-Gastroenterol 41: 359-361, 1994.
80. Tocci G, Conte A, Guarascio P and Visco G: Spontaneous remission of hepatocellular carcinoma after massive gastrointestinal hemorrhage. BMJ 300: 641-642, 1990.
81. van Halteren HK, Salemans JMJI, Peters H et al: Spontaneous regression of hepatocellular carcinoma. J Hepatol 27: 211-215, 1997.
82. Suzuki M, Okazaki N, Yoshino M and Yoshida T: Spontaneous regression of a hepatocellular carcinoma: a case report. Hepato-Gastroenterol 36: 160-163, 1989.
83. Bos SD and Mensink HJA: Spontaneous caval tumor thrombus necrosis and regression of pulmonary lesions in renal cell cancer. Scand J Urol Nephrol 30: 489-492, 1996.
84. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4-6, 1990.
85. Broder S and KarpJE: Progress against cancer. J Cancer Res Clin Oncol 121: 633-647, 1995.
86. O'Reilly MS, Holmgren L, Chen C, Folkman J: Angiostatin induced and sustained dormancy of human primary tumors in mice. Nature Med 2: 689-692, 1996.
87. Levy S, Herberman R. Lippman M et al: Corrrelation of stress factors with sustained depression of NK cell activity and predicted prognosis in patients with breast cancer. J Clin Oncol 5: 345-353, 1987.
88. Ader R and Cohen N: CNS-immune system instruction. Conditioning phenomenon. Behav Brain Sci 8: 379-394, 1985.
89. Kerr JFR, Winterford CM and Harman BV: Apoptosis Its significance in cancer and cancer therapy. Cancer 73: 2013-2026, 1994.
90. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462, 1995.
91. Wyllie AH: Apoptosis: an overview. Br Med Bull 53: 451-465, 1997.
92. Peter ME, Heufelde AE and Hengartner MO: Advances in apoptosis research. Proc Natl Acad Sci 94: 12736-12737, 1997.
93. Kaufman Y, Many A, Rechavi G et al: Brief report: Lymphoma with recurrent cycles of spontaneous remission and relapse- posssible role of apoptosis. N Eng J Med 332: 507-510, 1995.
94. Hoehner JC, Gestblom C, Olsen L and Pahlman S: Spatial association of apoptosis-related gene expression and cellular death in clinical neuroblastoma. Br J Cancer 75: 1185-1194, 1997.
95. Pansera F: Regression in renal carcinoma as re-expression of cell death in kidney development. Perspect Biol Med 35: 416-440, 1992.
96. Greger V, Passarge E, Hopping W et al: Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma. Hum Genet 83: 155-158, 1989.
97. Kim NW: Clinical implications of telomermase in cancer. Eur J Cancer 33: 781-786, 1997.
98. Yokoyama K, Matsuura T, Piatyszek MA et al: Correlating telomerase activity levels with human neuroblastoma outcome. Nature Med 1: 249-255, 1995.
99. Kaiser HE: Biological viewpoints of regression. In Vivo 8: 155-166, 1994.
100. Prehn RT: Cancers beget mutations versus metations beget cancers. Cancer Res 54: 5296-5300, 1994.